
Ophthalmology Medical Chain Institution

Innovative Drug Research and Development, Manufacturer

Therapeutic Area Product Development and Manufacturing
Original Title: Hong Kong Stocks’ Healthcare Sector Strengthens During Trading Session, Led by WuXi Biologics Source: China Securities Journal · CS.com.cn
China Securities Journal News (Reporter Zhou Lulu): On the morning of August 28, the healthcare sector in Hong Kong stocks strengthened during trading. According to Wind data, as of 10:45, the healthcare sector rose by 1.80%, leading all Hang Seng industry sectors; within the sector, WuXi Biologics led the gains with a 5.51% increase, followed by C-MER Medical and CSPC.Tong Ren TangTechnology,HECPharmaceuticals rose by more than 2% on average.